Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Eva Meixner"'
Autor:
Mike Ton, Maximilian Deng, Eva Meixner, Tanja Eichkorn, Anna Krämer, Katharina Seidensaal, Juliane Hörner-Rieber, Jonathan Lischalk, Klaus Herfarth, Jürgen Debus, Laila König
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-12 (2024)
Abstract Background Solitary fibrous tumors (SFT) of the central nervous system are rare and treatment options are not well established. The aim of this study was to evaluate the clinical outcomes of radiotherapy (RT) and re-radiotherapy (re-RT) for
Externí odkaz:
https://doaj.org/article/64a77ca77cf94825bd1c93d7a511903e
Autor:
Antje Wark MD, Anil Gupta MD, Eva Meixner MD, Laila König MD, Juliane Hörner-Rieber MD, Tobias Forster MD, Kristin Lang MD, Malte Ellerbrock MS, Klaus Herfarth MD, Jürgen Debus MD, PhD, Nathalie Arians MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Purpose: The aim of this matched-pair cohort study was to evaluate the potential of intensity-modulated proton therapy (IMPT) for sparring of the pelvic bone marrow and thus reduction of hematotoxicity compared to intensity-modulated photon radiother
Externí odkaz:
https://doaj.org/article/41419f0aba9c4ba7b901affdba193af3
Autor:
Eva Meixner, Antje Wark, Tobias Forster, Fabian Weykamp, Kristin Lang, Laila König, Katja Lindel, Jan Tobias Oelmann-Avendano, Johannes Krisam, Andreas Schneeweiss, Malte Ellerbrock, Thomas Mielke, Juliane Hörner-Rieber, Klaus Herfarth, Jürgen Debus, Nathalie Arians
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-14 (2023)
Abstract Introduction The APROVE-trial investigated the tolerability of postoperative proton beam therapy in women with cervical or endometrial cancer. The present analysis evaluated the secondary endpoints of health-related quality of life (HRQOL) a
Externí odkaz:
https://doaj.org/article/4227741b89e6454fa280584563593cd1
Autor:
Line Hoeltgen MD, Eva Meixner MD, Philipp Hoegen MD, Elisabetta Sandrini MD, Fabian Weykamp MD, Tobias Forster MD, Maria Vinsensia MD, Kristin Lang MD, Laila König MD, Nathalie Arians MD, Carlo Fremd MD, Laura L. Michel MD, Katharina Smetanay MD, Andreas Schneeweiss MD, Markus Wallwiener MD, Jürgen Debus MD, PhD, Juliane Hörner-Rieber MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Objective: Women with locally advanced breast cancer (LABC) or inoperable local recurrence often suffer from a significantly reduced quality of life (QOL) due to local tumor-associated pain, bleeding, exulceration, or malodorous discharge. We aimed t
Externí odkaz:
https://doaj.org/article/c06b98b514704b71a02c3567217cf054
Autor:
Eva Meixner, Juliane Hörner-Rieber, Jonathan W. Lischalk, Tanja Eichkorn, Anna Krämer, Elisabetta Sandrini, Angela Paul, Philipp Hoegen, Maximilian Deng, Thomas Welzel, Sinem Erdem, Jürgen Debus, Laila König
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100600- (2023)
Purpose: The appearance of radiation-induced contrast enhancements (RICE) after radiotherapy for brain metastases can go along with severe neurological impairments. The aim of our analysis was to evaluate radiological changes, the course and recurren
Externí odkaz:
https://doaj.org/article/c34f56871ed9489d8069368e99a39c7f
Autor:
Philipp Hoegen, Efthimios Katsigiannopulos, Carolin Buchele, Sebastian Regnery, Fabian Weykamp, Elisabetta Sandrini, Jonas Ristau, Jakob Liermann, Eva Meixner, Tobias Forster, C. Katharina Renkamp, Fabian Schlüter, Carolin Rippke, Jürgen Debus, Sebastian Klüter, Juliane Hörner-Rieber
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100567- (2023)
Purpose/Objective: To evaluate the potential of stereotactic magnetic resonance-guided online adaptive radiotherapy (SMART) to fulfill dose recommendations for stereotactic body radiotherapy (SBRT) of adrenal metastases and spare organs at risk (OAR)
Externí odkaz:
https://doaj.org/article/e1af0902239d47a9afbe696504bd0b64
Autor:
Kristin Lang, Thomas Held, Eva Meixner, Eric Tonndorf-Martini, Oliver Ristow, Julius Moratin, Nina Bougatf, Christian Freudlsperger, Jürgen Debus, Sebastian Adeberg
Publikováno v:
Head & Face Medicine, Vol 18, Iss 1, Pp 1-7 (2022)
Abstract Objectives Osteoradionecrosis (ORN) of the lower jaw is a serious late complication after radiotherapy in patients with oral cavity cancer. The aim of this study is to generate more insight into which patient- and treatment-related factors a
Externí odkaz:
https://doaj.org/article/9f2376d3c9e2451ab1fd019f73d2de85
Autor:
Eva Meixner MD, Line Hoeltgen MD, Philipp Hoegen MD, Laila König MD, Nathalie Arians MD, Laura L. Michel MD, Katharina Smetanay MD, Carlo Fremd MD, Andreas Schneeweiss MD, Jürgen Debus MD, PhD, Juliane Hörner-Rieber MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Introduction: In the adjuvant setting for cervical cancer, classical risk factors for postoperative radiochemotherapy have been established. However, data on laboratory changes during therapy and the prognostic value of serological markers are limite
Externí odkaz:
https://doaj.org/article/2d3fcd632edf4475ac677ed78770906a
Autor:
Eva Meixner, Ulrich Goldmann, Vitaly Sedlyarov, Stefania Scorzoni, Manuele Rebsamen, Enrico Girardi, Giulio Superti‐Furga
Publikováno v:
Molecular Systems Biology, Vol 16, Iss 7, Pp n/a-n/a (2020)
Abstract Solute carriers (SLCs) are the largest family of transmembrane transporters in the human genome with more than 400 members. Despite the fact that SLCs mediate critical biological functions and several are important pharmacological targets, a
Externí odkaz:
https://doaj.org/article/4729b0d838f84270bf07a144b76beea3
Autor:
Tanja Eichkorn, Jonathan W. Lischalk, Juliane Hörner-Rieber, Maximilian Deng, Eva Meixner, Anna Krämer, Philipp Hoegen, Elisabetta Sandrini, Sebastian Regnery, Thomas Held, Semi Harrabi, Christine Jungk, Klaus Herfarth, Jürgen Debus, Laila König
Publikováno v:
Journal of Neuro-Oncology. 162:489-501
Purpose Proton beam radiotherapy (PRT) has been demonstrated to improve neurocognitive sequelae particularly. Nevertheless, following PRT, increased rates of radiation-induced contrast enhancements (RICE) are feared. How safe and effective is PRT for